BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Fatty acid metabolic process
,
Ischemia
,
Adipose tissue
,
Pharmacogenetics
,
Lipitor
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
mag protein
Summary
General Info
Curated Studies
Most Correlated Studies
T-cells from healthy donor-derived PBMC after treatment with anti-CD3 antibodies
Effects of NgR overexpression on the developing and mature forebrain
Explore Curated Studies Results
Literature
Most Relevant Literature
Myelin-associated proteins are potential diagnostic markers in patients with primary brain tumour.
Decrease in Serum Anti-MAG Autoantibodies Is Associated With Therapy Response in Patients With Anti-…
Comparison between cerebrospinal fluid and serum levels of myelin-associated glycoprotein, total ant…
Focused ion beam-scanning electron microscopy links pathological myelin outfoldings to axonal change…
Clinical and laboratory features of anti-MAG neuropathy without monoclonal gammopathy.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Impact of 2.0g Daily of MAG-EPA on the AA/EPA Ratio and Inflammation Biomarkers in a Healthy Populat…
Lenalidomide in Anti-MAG Neuropathy: Phase 1b Study
Pro-resolving Effect of MAG-DHA in Cystic Fibrosis (PREMDIC)
Rituximab to Treat Neuropathy With Anti-MAG Antibodies
ACALA-R In Anti-MAG Neuropathy Mediated Neuropathy
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ